Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Changes in the Impact of Genitourinary Syndrome of Menopause With a Novel Nonhormonal Vulvovaginal Gel Assessed by PROMs. Phase 2, Single Arm, Interventional, Longitudinal, Clinical Trial. Part of STOP GSM PROJECT.

NCT06962345 is registered in ClinicalTrials.gov with Mucosa Innovations, S.L. as lead sponsor.

NCT NCT06962345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06962345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Changes in the Impact of Genitourinary Syndrome of Menopause With a Novel Nonhormonal Vulvovaginal Gel Assessed by PROMs. Phase 2, Single Arm, Interventional, Longitudinal, Clinical Trial. Part of STOP GSM PROJECT.
Lead sponsor
Mucosa Innovations, S.L.
Phase
Not applicable
Overall status
Recruiting
Start date
January 8, 2024
Completion date
December 31, 2026
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dyspareunia, genitourinary syndrome of menopause, menopause related conditions, quality of life, sexual function, urinary incontinence, urgency-frequency, vaginal dryness, vulvar atrophy, vulvovaginal signs and symptoms, women´s health